GRIFOLS SHARED SERVICES NORTH AMERICA, INC. for GRIFOLS SHARED SERVICES NORTH AMERICA INC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 1476 / S. 694, Preserving Life-Saving Access to Specialty Medicines in America Act (PLASMA Act), legislation to provide rebate phase-in for plasma-derived therapies under the Medicare Part D program H.R. 1143, Medicare IVIG Access Enhancement Act of 2025 H.R. 2343 , John W. Walsh Alpha-1 Home Infusion Act of 2025 H.R. 2172, Preserving Patient Access to Home Infusion Act S. 1818 / H.R.3546, Prescription Drug Price Relief Act of 2025 S.1587 / H.R.3375, Fair Prescription Drug Prices for Americans Act S.1753, End Price Gouging for Medications Act H.R. 3493, Global Fairness in Drug Pricing Act Issues related to the implementation of P.L. 117-169, The Inflation Reduction Act; drug price negotiations, Part D rebate
Foreign entity interest: Issues related to the delivery of plasma-derived therapies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROSEMARY GARZA | — |
| CHRISTOPHER HEALEY | — |
| KATHERINE PAJEWSKI | — |
| MICHAEL PIERSALL | — |
Immigration IMM
Issues related to immigration policy
Foreign entity interest: Issues related to the delivery of plasma-derived therapies
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROSEMARY GARZA | — |
| CHRISTOPHER HEALEY | — |
| KATHERINE PAJEWSKI | — |
| MICHAEL PIERSALL | — |
Budget/Appropriations BUD
FY2026 Appropriations bill for Health and Human Services; Medicare and Medicaid drug pricing and eligibility H.R. 1, One Big, Beautiful Bill Act; Medicare provisions - Most Favored Nations and drug pricing, Medicaid provisions - PBM Reform and eligibility, R&D tax credits
Foreign entity interest: Issues related to the delivery of plasma-derived therapies
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROSEMARY GARZA | — |
| CHRISTOPHER HEALEY | — |
| KATHERINE PAJEWSKI | — |
| MICHAEL PIERSALL | — |
Tariff (miscellaneous tariff bills) TAR
Issues related to tariff policy; tariffs on pharmaceuticals and related products
Foreign entity interest: Issues related to the delivery of plasma-derived therapies
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROSEMARY GARZA | — |
| CHRISTOPHER HEALEY | — |
| KATHERINE PAJEWSKI | — |
| MICHAEL PIERSALL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.